Cancer sequencing using next-generation sequencing (NGS) methods provides more information in less time compared to traditional single-gene and array-based approaches. With NGS, researchers can perform whole-genome studies, targeted gene profiling, tumor-normal comparisons, and more. NGS also offers the sensitivity to detect rare somatic variants, tumor subclones, and circulating DNA fragments.
See a comprehensive view of the unique mutations present in tumor tissue.
Learn MoreFocus on sequencing a set of genes or genomic regions with known cancer associations.
Learn MoreIdentify novel transcripts or determine which genes are overexpressed or underexpressed in tumors.
Learn MoreNGS offers the sensitivity and specificity that researchers need to detect low levels of ctDNA.
Learn MoreResearchers use various cancer sequencing methods to uncover somatic variants, methylation changes, and other genomic alterations associated with a deadly oral cancer.
Read ArticleWhole-genome sequencing of ctDNA samples enables researchers to analyze nucleosome patterns and infer the gene expression status of cancer driver genes.
Read ArticleResearchers utilize RNA sequencing to reveal how lncRNAs could be used to identify, measure, and treat cancer.
Read ArticleSimple, comprehensive workflows for a broad range of cancer research applications. The new 2023 guide includes: Single-cell sequencing, spatial sequencing, methylation profiling, multiomics, cell-free RNA sequencing and more!
Download Free GuideIllumina employees and the Illumina Corporate Foundation proudly support Stelvio for Life 2023
Read ArticleDeveloping and automating workflows for analyzing, processing, and sharing genomic data among researchers and clinicians.
Read InterviewAt ECP 2023, Illumina highlights value of comprehensive genomic profiling and integrating biomarkers into practice
Read ArticleThe user-friendly "Recommended Links" feature allows you to easily find content and products relevant to cancer research and/or a variety of other fields. You can access this option from the top of any illumina.com page.
Learn HowFind solutions that facilitate analysis of FFPE and limited (needle biopsy or aspirate) tumor DNA.
Wagle et al. demonstrate detection of genomic alterations in tumor samples by high-throughput sequencing.
An overview of recent cancer research publications featuring Illumina technology.
An overview of recent research publications exploring the interaction between tumor cells and the immune system.